Home > Journal Publications

Antiangiogenic and Antitumoral Effects Mediated by a Vascular Endothelial Growth Factor Receptor 1 (VEGFR-1)-Targeted DNAzyme

Hits:

Release time:2016-04-13
Affiliation of Author(s):Department of Oncology, Xiangya Hospital, Central South University
Journal:Molecular medicine
Place of Publication:US
Abstract:CONCLUSION These studies demonstrate that targeting VEGFR-1 is safe, and DNAzymes are potentially suitable as drug candidates for further clinical evaluat.
Co-author:Lun-Quan Sun, Lifang Yang, Zhijie Xu, Yan Chen, Weihua Liao, Ying Wang, Qin Zhou, Liangfang Shen
Indexed by:Unit Twenty Basic Research
Document Code:1076-1551(2013)01-0377-10.
Discipline:临床医学
Document Type:J
Volume:19
Issue:01
Page Number:377-386
ISSN No.:1076-1551
Translation or Not:no
Date of Publication:2013-10-30

Attachments:

Pre One:Outcomes and prognostic factors of conformal radiotherapy versus intensity-modulated radiotherapy for nasopharyngeal carcinoma

Next One:Dosimetric comparison of left-sided whole breast irradiation with 3D-CRT, IP-IMRT and hybrid IMRT